
What Is New With Pharmaceuticals Class Actions in October 2026? Latest court filings and settlement notices and Key Takeaways
File VSL#3, Kroger and generic-drug claims before October deadlines to protect your payout.
Read more →
File VSL#3, Kroger and generic-drug claims before October deadlines to protect your payout.
Read more →
For the first time, individual opioid victims know what the Purdue Pharma and Sackler settlement will pay them: $16,294 for a Tier 1 claim,...
Read more →
The $600 million Alibaba is paying over illegal drug and pill-press sales is not a settlement anyone can file a claim in. Alibaba Group...
Read more →
Deficiency letters are now going out in the Walgreens Savings Club settlement, and for claimants who get one, answering it on time can decide...
Read more →
Anyone who wants money from the $7 million Spectrum Pharmaceuticals securities settlement has to file by October 12, 2026 — nearly three weeks before...
Read more →
The $9.5 million Eagle Pharmaceuticals securities settlement is already approved, but the money only goes to EGRX investors who file a claim by October...
Read more →
Zoetis shareholders have until July 27, 2026 to apply as lead plaintiff in a federal securities lawsuit alleging the company concealed declining sales.
Read more →
A class action alleges acetaminophen makers withheld warnings about potential prenatal autism risks.
Read more →
The Suboxone dental injury claim allows users who experienced unexpected dental deterioration while taking the medication to seek compensation from the...
Read more →
Vivimed has agreed to pay $1.9 million to settle economic loss claims against consumers and insurers who purchased contaminated Losartan blood pressure...
Read more →
The Pradaxa internal bleeding class action settlement represents one of the largest pharmaceutical settlements related to anticoagulant medication risks.
Read more →
The OxyContin deceptive marketing class action settlement represents a historic $7.4 billion agreement approved by U.S.
Read more →
Risperdal, manufactured by Janssen Pharmaceuticals (a Johnson & Johnson subsidiary), was heavily marketed off-label to physicians treating elderly...
Read more →
The Vioxx Heart Attack Class Action Settlement represents one of the largest pharmaceutical settlements in U.S. history, with Merck agreeing to pay $4.
Read more →
Actos, a diabetes medication manufactured by Takeda Pharmaceuticals, was the subject of a $2.4 billion class action settlement that resolved thousands of...
Read more →
The Risperdal male breast growth gynecomastia class action represents one of the most significant pharmaceutical liability settlements involving Johnson &...
Read more →
The Xarelto internal bleeding class action settlement represents one of the largest pharmaceutical litigation resolutions in recent history, with Johnson...
Read more →
The Yaz and Yasmin birth control settlement represents one of the largest pharmaceutical class action settlements in U.S. history.
Read more →
The Essure permanent birth control system generated one of the largest medical device settlements in history: a 2020 class action settlement worth $1.
Read more →
The Seroquel XR $5.475 million pharmaceutical class action settlement represents a significant antitrust victory against AstraZeneca Pharmaceuticals LP,...
Read more →